ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance

Wu,Ping; Tang,Yaoyun; He,Jian; Qi,Lin; Jiang,Weihong; Zhao,Suping

doi:10.3892/or.2013.2622

ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance

Authors:
- Ping Wu
- Yaoyun Tang
- Jian He
- Lin Qi
- Weihong Jiang
- Suping Zhao
View Affiliations

Affiliations: Department of Otolaryngology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Published online on: July 18, 2013 https://doi.org/10.3892/or.2013.2622
Pages: 1807-1813

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Apoptosis repressor with caspase recruitment domain (ARC), an inhibitor of apoptosis, is primarily expressed in terminally differentiated tissues. Recent studies have revealed that ARC is highly expressed in a variety of human cancer cell lines and epithelial-derived cancers, which suggests that ARC plays an important role in the process of carcinogenesis. However, whether ARC is involved in the development of nasopharyngeal carcinoma (NPC) and the various roles it plays in NPC remain unclear. In the present study, we examined the expression of ARC in NPC cell lines and NPC tissues and the relationship between its subcellular expression and clinicopathological grade; moreover, we explored the effect of this protein on radiation resistance and chemoresistance in NPC cells. We found that cytoplasmic ARC was expressed at high levels in NPC tissues, at moderate levels in severe atypical hyperplasia and at low levels in benign nasopharyngeal tissues. High expression of cytoplasmic and nuclear ARC was correlated with advanced local invasion. However, only a small amount of nuclear ARC was expressed in NPC in contrast to cytoplasmic ARC. We also found that attenuation of ARC expression by miRNA resulted in decreased X-radiation and cisplatin resistance in NPC CNE-2 cells. In contrast, overexpression of ARC resulted in increased X-radiation and cisplatin resistance in NPC 6-10B cells. Furthermore, we demonstrated that ARC appears to be critical for blocking the activation of casapse-8 and casapse-2 in NPC cells subjected to X-radiation or cisplatin. These results suggest that high expression of ARC plays an important role in the pathogenesis of NPC and leads to X-radiation and cisplatin resistance in NPC.

View Figures

View References

1	Vaux DL and Strasser A: The molecular biology of apoptosis. Proc Natl Acad Sci USA. 93:2239–2244. 1996. View Article : Google Scholar
2	Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
3	Nam YJ, Mani K, Ashton AW, et al: Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell. 15:901–912. 2004. View Article : Google Scholar : PubMed/NCBI
4	Koseki T, Inohara N, Chen S, et al: ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA. 95:5156–5160. 1998. View Article : Google Scholar : PubMed/NCBI
5	Gustafsson AB, Tsai JG, Logue SE, et al: Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem. 279:21233–21238. 2004. View Article : Google Scholar : PubMed/NCBI
6	Foo RS, Nam YJ, Ostreicher MJ, et al: Regulation of p53 tetramerization and nuclear export by ARC. Proc Natl Acad Sci USA. 104:20826–20831. 2007. View Article : Google Scholar : PubMed/NCBI
7	Ekhterae D, Lin Z, Lundberg MS, et al: ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells. Circ Res. 85:e70–e77. 1999. View Article : Google Scholar : PubMed/NCBI
8	Neuss M, Monticone R, Lundberg MS, et al: The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function. J Biol Chem. 276:33915–33922. 2001. View Article : Google Scholar
9	Donath S, Li P, Willenbockel C, et al: Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation. 113:1203–1212. 2006. View Article : Google Scholar : PubMed/NCBI
10	Wu P, Zhang H, Qi L, et al: Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Oncol Rep. 27:987–994. 2012.PubMed/NCBI
11	Qi L, Wu P, Zhang X, et al: Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines. Med Oncol. 29:721–728. 2012. View Article : Google Scholar : PubMed/NCBI
12	Geertman R, McMahon A and Sabban EL: Cloning and characterization of cDNAs for novel proteins with glutamic acid-proline dipeptide tandem repeats. Biochim Biophys Acta. 1306:147–152. 1996. View Article : Google Scholar : PubMed/NCBI
13	Wang M, Qanungo S, Crow MT, et al: Apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei. FEBS Lett. 579:2411–2415. 2005. View Article : Google Scholar : PubMed/NCBI
14	Mercier I, Vuolo M, Madan R, et al: ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance. Cell Death Differ. 12:682–686. 2005. View Article : Google Scholar
15	Mercier I, Vuolo M, Jasmin JF, et al: ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer. Cell Cycle. 7:1640–1647. 2008. View Article : Google Scholar : PubMed/NCBI
16	Sarela AI, Macadam RC, Farmery SM, et al: Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 46:645–650. 2000. View Article : Google Scholar : PubMed/NCBI
17	Krajewska M, Krajewski S, Banares S, et al: Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res. 9:4914–4925. 2003.PubMed/NCBI
18	Tamm I, Kornblau SM, Segall H, et al: Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 6:1796–1803. 2000.PubMed/NCBI
19	Hanada M, Delia D, Aiello A, et al: bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood. 82:1820–1828. 1993.PubMed/NCBI
20	Olopade OI, Adeyanju MO, Safa AR, et al: Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am. 3:230–237. 1997.PubMed/NCBI
21	Friess H, Lu Z, Andren-Sandberg A, et al: Moderate activation of the apoptosis inhibitor bcl-Xl worsens the prognosis in pancreatic cancer. Ann Surg. 228:780–787. 1998. View Article : Google Scholar : PubMed/NCBI
22	Marone M, Scambia G, Mozzetti S, et al: bcl-2, bax, bcl-XL and bcl-XS expression in normal and neoplastic ovarian tissues. Clin Cancer Res. 4:517–524. 1998.PubMed/NCBI
23	Biroccio A, Benassi B, D’Agnano I, et al: c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings. Am J Pathol. 158:1289–1299. 2001. View Article : Google Scholar : PubMed/NCBI
24	Takayama T, Nagao M, Sawada H, et al: Bcl-X expression in esophageal squamous cell carcinoma: association with tumor progression and prognosis. J Surg Oncol. 78:116–123. 2001. View Article : Google Scholar : PubMed/NCBI
25	Verma YK, Raghav PK, Raj HG, et al: Enhanced heterodimerization of Bax by Bcl-2 mutants improves irradiated cell survival. Apoptosis. 18:212–225. 2013. View Article : Google Scholar : PubMed/NCBI
26	Huang S, Benavente S, Armstrong EA, et al: p53 modulates acquired resistance to EGFR inhibitors and radiation. Cancer Res. 71:7071–7079. 2011. View Article : Google Scholar : PubMed/NCBI
27	Gong JG, Costanzo A, Yang HQ, et al: The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:806–809. 1999. View Article : Google Scholar : PubMed/NCBI
28	Carter BZ, Qiu YH, Zhang N, et al: Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML. Blood. 117:780–787. 2011. View Article : Google Scholar : PubMed/NCBI
29	Chen T, Chen M and Chen J: Ionizing radiation potentiates dihydroartemisinin-induced apoptosis of A549 cells via a caspase-8-dependent pathway. PLoS One. 8:e598272013. View Article : Google Scholar : PubMed/NCBI
30	Paul I, Chacko AD, Stasik I, et al: Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer. Cell Death Dis. e4492012. View Article : Google Scholar : PubMed/NCBI
31	Cao X, Bennett RL and May WS: c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis. J Biol Chem. 283:14490–14496. 2008. View Article : Google Scholar : PubMed/NCBI
32	Hanoux V, Pairault C, Bakalska M, et al: Caspase-2 involvement during ionizing radiation-induced oocyte death in the mouse ovary. Cell Death Differ. 14:671–681. 2007. View Article : Google Scholar : PubMed/NCBI
33	Wang S and El-Deiry WS: TRAIL and apoptosis induction by TNF-family death receptors. Oncogene. 22:8628–8633. 2003. View Article : Google Scholar : PubMed/NCBI
34	Cuenin S, Tinel A, Janssens S, et al: p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress. Oncogene. 27:387–396. 2008. View Article : Google Scholar : PubMed/NCBI
35	Lassus P, Opitz-Araya X and Lazebnik Y: Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science. 297:1352–1354. 2002. View Article : Google Scholar : PubMed/NCBI